糖尿病肾病患者血清VEGF水平的变化被引量：6

下载PDF

导出

摘要目的通过糖尿病肾病患者的血清血管内皮生长因子(VEGF)水平的变化以探讨其在糖尿病肾病发生、发展过程的临床意义。方法以我院收集糖尿病肾病患者30例为观察组,以健康体检者35例为对照组,采用酶联免疫吸附试验(ELISA)检测两组血清VEGF水平。结果糖尿病肾病患者组血清VEGF水平显著高于正常对照组(P<0.01)。结论血清VEGF的异常高水平可能与糖尿病肾病的发生发展有关,其浓度变化可用于监测糖尿病肾病病程进展及转归。

作者曾益林捷金静君

机构地区福建省级机关医院肾内科福建省医学科学研究院

出处《福建医药杂志》 CAS 2015年第4期69-71,共3页 Fujian Medical Journal

关键词糖尿病肾病 VEGF 酶联免疫吸附试验

分类号 R587.2 [医药卫生—内分泌] R692.9 [医药卫生—泌尿科学] R446.5 [医药卫生—诊断学]

引文网络
相关文献

参考文献6

1Schrijvers B F, De Vriese A S, Flyvbjerg A. From Hypergly-cemia to diabetic kidney disease: the role of metablic, hemody- namic intracellular factors and growth factors/cytokines [J]. Endocr Rev, 2004, 25 (6): 971-1010.
2Hoshi S, Shu Y, Yoshida F, et al. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats [J]. Lab Invest, 2002, 82 (1): 25-35.
3Bonnefond A, Saulnier P J, Stathopoulou M G, et al. What is the contribution of two genetic variants regulating VEGF' levels to type 2 diabetes risk and to microvaseular complications? [J]. PloSOne, 2013, 8 (2): 55921.
4Fiorentino L, Cavalera M, Menini S, et al. Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay [J]. EMBOMolMed, 2013, 5 (3): 441-455.
5林辉.血管内皮生长因子与糖尿病肾病[J].国外医学（内分泌学分册）,2002,22(3):186-188. 被引量：7
6王玉梅,汪宏波,朱忠华,邓安国.血管内皮生长因子与肾脏疾病[J].国外医学（泌尿系统分册）,2000,20(4):176-179. 被引量：9

二级参考文献16

1Thomas S, Vanuystel J, Gruden G, et al. Vascular endothelial growt h factor receptors in human mesangium in vitro and in glomerular disease[J]. J Am Soc Nephol,2000,11:1236-1243.
2Shulman K, Rosen S, Tognazzi K, et al. Expression of vascula r permeability factor (VPF/VEGF) is altered in many glomerular diseases[J].J Am Soc Nephol,1996,7:661-666.
3Cooper M E, Vranes D, Youssef S, et al. Increased renal exp ression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental di abetes[J].Diabetes,1999,48:2229-2239.
4Cha D R, Kim N H, Yoon J W, et al. Role of vascular endothel ial growth factor in diabetic nephropathy[J].Kidney Int,2000,58 (Suppl 77):S104-S 112.
5Antonetti D A, Barber A J, Khin S, et al. Vascular permeabil ity in experim ental diabetes is associated with reduced endothelial cells. Penn State Retina Research Group[J].Diabetes,1998,47:1953-1959.
6Antonetti D A, Barber A J, Hollinger L A, et al. Vascular en dothel ial growth factor induces rapid phosphorylation of tight junction proteins occlu din and zonula occludens 1. A potential mechanisms for vascular permeability in diabetic retinopathy and tumors[J].J Biol Chem,1999,274:23463-23467.
7Feng Y, Venema V J, Venema R C, et al. VEGF-induced permeabilit y increase is mediated by caveolae[J].Invest Ophthalmol Vis Sci,1999,40:157-1 67.
8Esser S, Wolburg K, Wolburg H, et al. Vascular endothelial growth factor induces endothelial fenestration in vivo[J].J Cell Biol,1998,140:947- 959.
9Amemiya T, Sasamura H, Mifune M, et al. Vascular endothelial grow th facto r activates MAP kinase and enhances collagen synthesis in human mesangial cells [J].Kidney Int,1999,56:2055-2063.
10Stephan C C, Chang K C, Leijeune W, et al. Role for heparin-bind ing growth factors in glucose-induced vascular dysfunction[J].Diabetes,1998,4 7:1771-1778.